| Literature DB >> 25844048 |
W Joe Acton1, Matteo Lanza2, Bishu Agarwal3, Simone Jürschik3, Philipp Sulzer3, Kostiantyn Breiev2, Alfons Jordan3, Eugen Hartungen3, Gernot Hanel3, Lukas Märk3, Chris A Mayhew4, Tilmann D Märk2.
Abstract
The rapid expansion in the number and use of new psychoactive substances presents a significant analytical challenge because highly sensitive instrumentation capable of detecting a broad range of chemical compounds in real-time with a low rate of false positives is required. A Selective Reagent Ionisation-Time of Flight-Mass Spectrometry (Entities:
Keywords: Branching ratios; Drug detection; New psychoactive substances; PTR-MS; SRI-TOF-MS
Year: 2014 PMID: 25844048 PMCID: PMC4375562 DOI: 10.1016/j.ijms.2013.12.009
Source DB: PubMed Journal: Int J Mass Spectrom ISSN: 1387-3806 Impact factor: 1.986
Fig. 1Chemical structures of (a) 4-fluoroamphetamine, (b) methiopropamine, (c) 5-(2-aminopropyl)benzofuran, (d) ethcathinone, (e) 4-methylethcathinone, (f) N-ethylbuphedrone, (g) ethylphenidate, (h) 5-MeO-DALT, (i) dimethocaine and (j) nitracaine.
List of the investigated drugs (in order of increasing mass) and the product ions and their associated percentage ion branching ratios (in brackets) for reactions with H3O+, NO+, O2+ and Kr+, recorded at E/N of 130 Td (45 Td in case of Kr+). NR is used to represent no reaction and NOP means no observable product ions that can be identified to the drug as a result of substantial fragmentation.
| Compound name | H3O+ | NO+ | O2+ | Kr+ |
|---|---|---|---|---|
| 4-Fluoroamphetamine (C9H12FN; | ||||
| Methiopropamine (C8H13NS; | ||||
| 5-(2-Aminopropyl)benzofuran (C11H13NO; | NOP | |||
| Ethcathinone (C11H15NO; | ||||
| 4-Methylethcathinone (C12H17NO; | ||||
| N-Ethylbuphedrone (C12H17NO; | ||||
| Ethylphenidate (C15H21NO2; | NR | NOP | NOP | |
| 5-MeO-DALT (C17H22N2O; | NOP | |||
| Dimethocaine (C16H26N2O2; | ||||
| Nitracaine (C16H24N2O4; | Crystal: | NR | NR | NOP |
Fig. 2The variation of the percentage product ion branching ratios following the reactions of the various drug compounds with H3O+ as a function of E/N for (a) 4-fluoroamphetamine, (b) methiopropamine, (c) 5-(2-aminopropyl)benzofuran, (d) ethcathinone, (e) 4-methylethcathinone, (f) N-ethylbuphedrone, (g) ethylphenidate, (h) 5-MeO-DALT and (i) dimethocaine.
Fig. 3The variation of the percentage product ion branching ratios following the reactions of the drug species with NO+ as a function of E/N for (a) 4-fluoroamphetamine, (b) methiopropamine, (c) 5-(2-aminopropyl)benzofuran, (d) ethcathinone, (e) 4-methylethcathinone, (f) N-ethylbuphedrone, (g) 5-MeO-DALT and (h) dimethocaine.
Fig. 4The variation of the percentage product ion branching ratios following the reactions of the drug species with O2+ as a function of E/N for (a) 4-fluoroamphetamine, (b) methiopropamine, (c) 5-(2-aminopropyl)benzofuran, (d) ethcathinone, (e) 4-methylethcathinone, (f) N-ethylbuphedrone, (g) 5-MeO-DALT and (h) dimethocaine.
Fig. 5The variation of the percentage product ion branching ratios following the reactions of the drug species with Kr+ as a function of E/N for (a) 4-fluoroamphetamine, (b) methiopropamine, (c) ethcathinone and (d) N-ethylbuphedrone.